Overexpression of FoxO1 has been reported to act against hyperglycemia-induced oxidative stress, and prevent β cell replication in an insulin-resistant state through decreasing glucose utilization and insulin secretion, a process known as “metabolic diapause” [28]. The gene discussed is INS; the disease is Hyperglycemia.